BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04949256-completion@plaintrial.com
DTSTAMP:20261028T111643Z
DTSTART;VALUE=DATE:20260612
SUMMARY:Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E70
 80/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal C
 arcinoma (MK-7902-014/E7080-G000-320/LEAP-014) — estimated completion da
 te
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04949256
URL:https://plaintrial.com/trial/NCT04949256
END:VEVENT
END:VCALENDAR